ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
NRX Pharmaceuticals Inc

NRX Pharmaceuticals Inc (NRXP)

4,16
0,215
(5,45%)
Fermé 08 Juillet 10:00PM
4,1205
-0,0395
(-0,95%)
Après les heures de négociation: 1:59AM

NRX Pharmaceuticals Inc (NRXP) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
4,1205
( 4,45% )
Prix Achat
4,08
Prix Vente
4,20
Volume échangé
965 015
Volume moyen (3 m)
US$ 1 285 696
Volume financier
US$ 3 900 986
3,87 Fourchette du Jour 4,22
0,00 Plage de 52 semaines 0,00
Cap du marché
Valeur d'Entreprise
156,414M
Clôture Veille
3,945
Ouverture
3,95
Dernière Transaction
4758
@
4.1205
(formt)
Dernière heure de transaction
VWAP
4,0424
Chiffre d'affairess (LTM)
2,29M
Bénéfice net (LTM)
-24,54M
Actions en circulation
41 910 383
Flottant (%)
86,29%
Détention Institutionnelle (%)
19,11%
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-4
Ratio Cours/Ventes (P/S)
70,73
Bénéfice par action (BPA)
-0,97
Bêta
2,19

À propos de NRX Pharmaceuticals Inc

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments.... NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior; NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression; and KETAFREE, a generic preservative-free formulation of ketamine. It also provides precision-based interventional psychiatry services to patients with treatment-resistant depression and PTSD using a combination of neuroplastic drugs, transcranial magnetic stimulation (TMS), digital therapeutics, and hyperbaric therapy; ketamine infusion therapy; stellate ganglion blocks; Spravato administration; psychotherapy; and medication management. The company has a development and license agreement with Glytech LLC. NRx Pharmaceuticals, Inc. was founded in 2015 and is headquartered in Wilmington, Delaware. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Siège social
Wilmington, United States
Fondé
2026
NRX Pharmaceuticals Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker NRXP. Le dernier cours de clôture d'NRX Pharmaceuticals était de US$3,95. Au cours de la dernière année, les actions de NRX Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 0,00 à US$ 0,00.

NRX Pharmaceuticals compte actuellement 41 910 383 actions en circulation. La capitalisation boursière d'NRX Pharmaceuticals est de US$172,69 million. NRX Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -4.00.

NRXP Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

NRXP - Frequently Asked Questions (FAQ)

What is the current NRX Pharmaceuticals Inc share price?
The current share price of NRX Pharmaceuticals Inc is US$ 4,1205
How many NRX Pharmaceuticals Inc shares are in issue?
NRX Pharmaceuticals Inc has 41 910 383 shares in issue
What is the market cap of NRX Pharmaceuticals Inc?
The market capitalisation of NRX Pharmaceuticals Inc is USD 172,69M
What is the 1 year trading range for NRX Pharmaceuticals Inc share price?
NRX Pharmaceuticals Inc has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of NRX Pharmaceuticals Inc?
The price to earnings ratio of NRX Pharmaceuticals Inc is -4
What is the cash to sales ratio of NRX Pharmaceuticals Inc?
The cash to sales ratio of NRX Pharmaceuticals Inc is 70,73
What is the registered address of NRX Pharmaceuticals Inc?
The registered address for NRX Pharmaceuticals Inc is 1201 N. Market Street, Wilmington, Delaware, 19801
What is the NRX Pharmaceuticals Inc website address?
The website address for NRX Pharmaceuticals Inc is www.nrxpharma.com
Which industry sector does NRX Pharmaceuticals Inc operate in?
NRX Pharmaceuticals Inc operates in the Biotechnology & Life Sciences sector

NRXP Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock